English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 108 | Tables: 211 | Pharma & Healthcare
The global Antipsychotic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Drug.
Report Scope
The Antipsychotic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipsychotic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Sumitomo Dainippon Pharma
Allergan
Novartis
Cardinal Health
Sun Pharmaceutical Industries
GlaxoSmithKline
Sanis Health
Qilu Pharmaceutical
Otsuka Pharmaceutical
Vanda Pharmaceuticals
H.Lundbeck
Organon
Hansoh
Hengrui
Nhwa Group
Yangtze River Pharmaceutical Group
Segment by Type
First Generation Antipsychotics Drug
Second Generation Antipsychotics Drug
Third generation Antipsychotics Drug
Segment by Application
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipsychotic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipsychotic Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 First Generation Antipsychotics Drug
1.2.3 Second Generation Antipsychotics Drug
1.2.4 Third generation Antipsychotics Drug
1.3 Market by Application
1.3.1 Global Antipsychotic Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bipolar I Disorder
1.3.3 Schizophrenia
1.3.4 Schizoaffective Disorder
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Drug Market Perspective (2019-2030)
2.2 Antipsychotic Drug Growth Trends by Region
2.2.1 Global Antipsychotic Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antipsychotic Drug Historic Market Size by Region (2019-2024)
2.2.3 Antipsychotic Drug Forecasted Market Size by Region (2025-2030)
2.3 Antipsychotic Drug Market Dynamics
2.3.1 Antipsychotic Drug Industry Trends
2.3.2 Antipsychotic Drug Market Drivers
2.3.3 Antipsychotic Drug Market Challenges
2.3.4 Antipsychotic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipsychotic Drug Players by Revenue
3.1.1 Global Top Antipsychotic Drug Players by Revenue (2019-2024)
3.1.2 Global Antipsychotic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Antipsychotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antipsychotic Drug Revenue
3.4 Global Antipsychotic Drug Market Concentration Ratio
3.4.1 Global Antipsychotic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Drug Revenue in 2023
3.5 Antipsychotic Drug Key Players Head office and Area Served
3.6 Key Players Antipsychotic Drug Product Solution and Service
3.7 Date of Enter into Antipsychotic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Drug Breakdown Data by Type
4.1 Global Antipsychotic Drug Historic Market Size by Type (2019-2024)
4.2 Global Antipsychotic Drug Forecasted Market Size by Type (2025-2030)
5 Antipsychotic Drug Breakdown Data by Application
5.1 Global Antipsychotic Drug Historic Market Size by Application (2019-2024)
5.2 Global Antipsychotic Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antipsychotic Drug Market Size (2019-2030)
6.2 North America Antipsychotic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antipsychotic Drug Market Size by Country (2019-2024)
6.4 North America Antipsychotic Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antipsychotic Drug Market Size (2019-2030)
7.2 Europe Antipsychotic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antipsychotic Drug Market Size by Country (2019-2024)
7.4 Europe Antipsychotic Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Drug Market Size (2019-2030)
8.2 Asia-Pacific Antipsychotic Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antipsychotic Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Antipsychotic Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antipsychotic Drug Market Size (2019-2030)
9.2 Latin America Antipsychotic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antipsychotic Drug Market Size by Country (2019-2024)
9.4 Latin America Antipsychotic Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Drug Market Size (2019-2030)
10.2 Middle East & Africa Antipsychotic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antipsychotic Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Antipsychotic Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Antipsychotic Drug Introduction
11.1.4 Johnson & Johnson Revenue in Antipsychotic Drug Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Antipsychotic Drug Introduction
11.2.4 Pfizer Revenue in Antipsychotic Drug Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Antipsychotic Drug Introduction
11.3.4 Eli Lilly Revenue in Antipsychotic Drug Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Bristol Myers Squibb
11.4.1 Bristol Myers Squibb Company Detail
11.4.2 Bristol Myers Squibb Business Overview
11.4.3 Bristol Myers Squibb Antipsychotic Drug Introduction
11.4.4 Bristol Myers Squibb Revenue in Antipsychotic Drug Business (2019-2024)
11.4.5 Bristol Myers Squibb Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Antipsychotic Drug Introduction
11.5.4 AstraZeneca Revenue in Antipsychotic Drug Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Sumitomo Dainippon Pharma
11.6.1 Sumitomo Dainippon Pharma Company Detail
11.6.2 Sumitomo Dainippon Pharma Business Overview
11.6.3 Sumitomo Dainippon Pharma Antipsychotic Drug Introduction
11.6.4 Sumitomo Dainippon Pharma Revenue in Antipsychotic Drug Business (2019-2024)
11.6.5 Sumitomo Dainippon Pharma Recent Development
11.7 Allergan
11.7.1 Allergan Company Detail
11.7.2 Allergan Business Overview
11.7.3 Allergan Antipsychotic Drug Introduction
11.7.4 Allergan Revenue in Antipsychotic Drug Business (2019-2024)
11.7.5 Allergan Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Antipsychotic Drug Introduction
11.8.4 Novartis Revenue in Antipsychotic Drug Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Cardinal Health
11.9.1 Cardinal Health Company Detail
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Antipsychotic Drug Introduction
11.9.4 Cardinal Health Revenue in Antipsychotic Drug Business (2019-2024)
11.9.5 Cardinal Health Recent Development
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Company Detail
11.10.2 Sun Pharmaceutical Industries Business Overview
11.10.3 Sun Pharmaceutical Industries Antipsychotic Drug Introduction
11.10.4 Sun Pharmaceutical Industries Revenue in Antipsychotic Drug Business (2019-2024)
11.10.5 Sun Pharmaceutical Industries Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Antipsychotic Drug Introduction
11.11.4 GlaxoSmithKline Revenue in Antipsychotic Drug Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Development
11.12 Sanis Health
11.12.1 Sanis Health Company Detail
11.12.2 Sanis Health Business Overview
11.12.3 Sanis Health Antipsychotic Drug Introduction
11.12.4 Sanis Health Revenue in Antipsychotic Drug Business (2019-2024)
11.12.5 Sanis Health Recent Development
11.13 Qilu Pharmaceutical
11.13.1 Qilu Pharmaceutical Company Detail
11.13.2 Qilu Pharmaceutical Business Overview
11.13.3 Qilu Pharmaceutical Antipsychotic Drug Introduction
11.13.4 Qilu Pharmaceutical Revenue in Antipsychotic Drug Business (2019-2024)
11.13.5 Qilu Pharmaceutical Recent Development
11.14 Otsuka Pharmaceutical
11.14.1 Otsuka Pharmaceutical Company Detail
11.14.2 Otsuka Pharmaceutical Business Overview
11.14.3 Otsuka Pharmaceutical Antipsychotic Drug Introduction
11.14.4 Otsuka Pharmaceutical Revenue in Antipsychotic Drug Business (2019-2024)
11.14.5 Otsuka Pharmaceutical Recent Development
11.15 Vanda Pharmaceuticals
11.15.1 Vanda Pharmaceuticals Company Detail
11.15.2 Vanda Pharmaceuticals Business Overview
11.15.3 Vanda Pharmaceuticals Antipsychotic Drug Introduction
11.15.4 Vanda Pharmaceuticals Revenue in Antipsychotic Drug Business (2019-2024)
11.15.5 Vanda Pharmaceuticals Recent Development
11.16 H.Lundbeck
11.16.1 H.Lundbeck Company Detail
11.16.2 H.Lundbeck Business Overview
11.16.3 H.Lundbeck Antipsychotic Drug Introduction
11.16.4 H.Lundbeck Revenue in Antipsychotic Drug Business (2019-2024)
11.16.5 H.Lundbeck Recent Development
11.17 Organon
11.17.1 Organon Company Detail
11.17.2 Organon Business Overview
11.17.3 Organon Antipsychotic Drug Introduction
11.17.4 Organon Revenue in Antipsychotic Drug Business (2019-2024)
11.17.5 Organon Recent Development
11.18 Hansoh
11.18.1 Hansoh Company Detail
11.18.2 Hansoh Business Overview
11.18.3 Hansoh Antipsychotic Drug Introduction
11.18.4 Hansoh Revenue in Antipsychotic Drug Business (2019-2024)
11.18.5 Hansoh Recent Development
11.19 Hengrui
11.19.1 Hengrui Company Detail
11.19.2 Hengrui Business Overview
11.19.3 Hengrui Antipsychotic Drug Introduction
11.19.4 Hengrui Revenue in Antipsychotic Drug Business (2019-2024)
11.19.5 Hengrui Recent Development
11.20 Nhwa Group
11.20.1 Nhwa Group Company Detail
11.20.2 Nhwa Group Business Overview
11.20.3 Nhwa Group Antipsychotic Drug Introduction
11.20.4 Nhwa Group Revenue in Antipsychotic Drug Business (2019-2024)
11.20.5 Nhwa Group Recent Development
11.21 Yangtze River Pharmaceutical Group
11.21.1 Yangtze River Pharmaceutical Group Company Detail
11.21.2 Yangtze River Pharmaceutical Group Business Overview
11.21.3 Yangtze River Pharmaceutical Group Antipsychotic Drug Introduction
11.21.4 Yangtze River Pharmaceutical Group Revenue in Antipsychotic Drug Business (2019-2024)
11.21.5 Yangtze River Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antipsychotic Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of First Generation Antipsychotics Drug
Table 3. Key Players of Second Generation Antipsychotics Drug
Table 4. Key Players of Third generation Antipsychotics Drug
Table 5. Global Antipsychotic Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antipsychotic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antipsychotic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Antipsychotic Drug Market Share by Region (2019-2024)
Table 9. Global Antipsychotic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Antipsychotic Drug Market Share by Region (2025-2030)
Table 11. Antipsychotic Drug Market Trends
Table 12. Antipsychotic Drug Market Drivers
Table 13. Antipsychotic Drug Market Challenges
Table 14. Antipsychotic Drug Market Restraints
Table 15. Global Antipsychotic Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Antipsychotic Drug Market Share by Players (2019-2024)
Table 17. Global Top Antipsychotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2023)
Table 18. Ranking of Global Top Antipsychotic Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Antipsychotic Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antipsychotic Drug Product Solution and Service
Table 22. Date of Enter into Antipsychotic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antipsychotic Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Antipsychotic Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Antipsychotic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Antipsychotic Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Antipsychotic Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Antipsychotic Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Antipsychotic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Antipsychotic Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Antipsychotic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Antipsychotic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Antipsychotic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Antipsychotic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Antipsychotic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Antipsychotic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Antipsychotic Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Antipsychotic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Antipsychotic Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Antipsychotic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Antipsychotic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Antipsychotic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Antipsychotic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Antipsychotic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Antipsychotic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Johnson & Johnson Company Detail
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Antipsychotic Drug Product
Table 50. Johnson & Johnson Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Antipsychotic Drug Product
Table 55. Pfizer Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Eli Lilly Company Detail
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Antipsychotic Drug Product
Table 60. Eli Lilly Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Bristol Myers Squibb Company Detail
Table 63. Bristol Myers Squibb Business Overview
Table 64. Bristol Myers Squibb Antipsychotic Drug Product
Table 65. Bristol Myers Squibb Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 66. Bristol Myers Squibb Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Antipsychotic Drug Product
Table 70. AstraZeneca Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Sumitomo Dainippon Pharma Company Detail
Table 73. Sumitomo Dainippon Pharma Business Overview
Table 74. Sumitomo Dainippon Pharma Antipsychotic Drug Product
Table 75. Sumitomo Dainippon Pharma Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 76. Sumitomo Dainippon Pharma Recent Development
Table 77. Allergan Company Detail
Table 78. Allergan Business Overview
Table 79. Allergan Antipsychotic Drug Product
Table 80. Allergan Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. Novartis Company Detail
Table 83. Novartis Business Overview
Table 84. Novartis Antipsychotic Drug Product
Table 85. Novartis Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Cardinal Health Company Detail
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Antipsychotic Drug Product
Table 90. Cardinal Health Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 91. Cardinal Health Recent Development
Table 92. Sun Pharmaceutical Industries Company Detail
Table 93. Sun Pharmaceutical Industries Business Overview
Table 94. Sun Pharmaceutical Industries Antipsychotic Drug Product
Table 95. Sun Pharmaceutical Industries Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 96. Sun Pharmaceutical Industries Recent Development
Table 97. GlaxoSmithKline Company Detail
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Antipsychotic Drug Product
Table 100. GlaxoSmithKline Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 101. GlaxoSmithKline Recent Development
Table 102. Sanis Health Company Detail
Table 103. Sanis Health Business Overview
Table 104. Sanis Health Antipsychotic Drug Product
Table 105. Sanis Health Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 106. Sanis Health Recent Development
Table 107. Qilu Pharmaceutical Company Detail
Table 108. Qilu Pharmaceutical Business Overview
Table 109. Qilu Pharmaceutical Antipsychotic Drug Product
Table 110. Qilu Pharmaceutical Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 111. Qilu Pharmaceutical Recent Development
Table 112. Otsuka Pharmaceutical Company Detail
Table 113. Otsuka Pharmaceutical Business Overview
Table 114. Otsuka Pharmaceutical Antipsychotic Drug Product
Table 115. Otsuka Pharmaceutical Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 116. Otsuka Pharmaceutical Recent Development
Table 117. Vanda Pharmaceuticals Company Detail
Table 118. Vanda Pharmaceuticals Business Overview
Table 119. Vanda Pharmaceuticals Antipsychotic Drug Product
Table 120. Vanda Pharmaceuticals Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 121. Vanda Pharmaceuticals Recent Development
Table 122. H.Lundbeck Company Detail
Table 123. H.Lundbeck Business Overview
Table 124. H.Lundbeck Antipsychotic Drug Product
Table 125. H.Lundbeck Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 126. H.Lundbeck Recent Development
Table 127. Organon Company Detail
Table 128. Organon Business Overview
Table 129. Organon Antipsychotic Drug Product
Table 130. Organon Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 131. Organon Recent Development
Table 132. Hansoh Company Detail
Table 133. Hansoh Business Overview
Table 134. Hansoh Antipsychotic Drug Product
Table 135. Hansoh Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 136. Hansoh Recent Development
Table 137. Hengrui Company Detail
Table 138. Hengrui Business Overview
Table 139. Hengrui Antipsychotic Drug Product
Table 140. Hengrui Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 141. Hengrui Recent Development
Table 142. Nhwa Group Company Detail
Table 143. Nhwa Group Business Overview
Table 144. Nhwa Group Antipsychotic Drug Product
Table 145. Nhwa Group Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 146. Nhwa Group Recent Development
Table 147. Yangtze River Pharmaceutical Group Company Detail
Table 148. Yangtze River Pharmaceutical Group Business Overview
Table 149. Yangtze River Pharmaceutical Group Antipsychotic Drug Product
Table 150. Yangtze River Pharmaceutical Group Revenue in Antipsychotic Drug Business (2019-2024) & (US$ Million)
Table 151. Yangtze River Pharmaceutical Group Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antipsychotic Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antipsychotic Drug Market Share by Type: 2023 VS 2030
Figure 3. First Generation Antipsychotics Drug Features
Figure 4. Second Generation Antipsychotics Drug Features
Figure 5. Third generation Antipsychotics Drug Features
Figure 6. Global Antipsychotic Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Antipsychotic Drug Market Share by Application: 2023 VS 2030
Figure 8. Bipolar I Disorder Case Studies
Figure 9. Schizophrenia Case Studies
Figure 10. Schizoaffective Disorder Case Studies
Figure 11. Others Case Studies
Figure 12. Antipsychotic Drug Report Years Considered
Figure 13. Global Antipsychotic Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Antipsychotic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antipsychotic Drug Market Share by Region: 2023 VS 2030
Figure 16. Global Antipsychotic Drug Market Share by Players in 2023
Figure 17. Global Top Antipsychotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Antipsychotic Drug Revenue in 2023
Figure 19. North America Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Antipsychotic Drug Market Share by Country (2019-2030)
Figure 21. United States Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antipsychotic Drug Market Share by Country (2019-2030)
Figure 25. Germany Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antipsychotic Drug Market Share by Region (2019-2030)
Figure 33. China Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antipsychotic Drug Market Share by Country (2019-2030)
Figure 41. Mexico Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antipsychotic Drug Market Share by Country (2019-2030)
Figure 45. Turkey Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Antipsychotic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Johnson & Johnson Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 49. Eli Lilly Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 52. Sumitomo Dainippon Pharma Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 53. Allergan Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 55. Cardinal Health Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 58. Sanis Health Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 59. Qilu Pharmaceutical Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 60. Otsuka Pharmaceutical Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 61. Vanda Pharmaceuticals Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 62. H.Lundbeck Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 63. Organon Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 64. Hansoh Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 65. Hengrui Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 66. Nhwa Group Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 67. Yangtze River Pharmaceutical Group Revenue Growth Rate in Antipsychotic Drug Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
